CN104546629A - Hydrating and whitening eye cream - Google Patents

Hydrating and whitening eye cream Download PDF

Info

Publication number
CN104546629A
CN104546629A CN201310497741.0A CN201310497741A CN104546629A CN 104546629 A CN104546629 A CN 104546629A CN 201310497741 A CN201310497741 A CN 201310497741A CN 104546629 A CN104546629 A CN 104546629A
Authority
CN
China
Prior art keywords
parts
eye cream
eye
hydrating
glycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310497741.0A
Other languages
Chinese (zh)
Inventor
罗鹏程
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310497741.0A priority Critical patent/CN104546629A/en
Publication of CN104546629A publication Critical patent/CN104546629A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

The invention discloses hydrating and whitening eye cream. The hydrating and whitening eye cream is characterized by comprising the following constituents in parts by weight: 3 to 5 parts of pearl, 2 to 4 parts of borax, 0.3 to 0.5 part of ketone musk, 2 to 3 parts of oil phase, 0.2 to 0.4 part of zinc carbonate hydroxide, 1 to 2 parts of an alcohol mixture, 0.05 to 0.08 part of glycerol monostearate, 0.06 to 0.08 part of hydroxybenzoic acid propyl este, 5 to 7 parts of glycerin, 0.8 to 1 part of polyacrylamide, 0.1 to 0.3 part of ethylenediaminetetraacetic acid disodium salt, 0.2 to 0.5 part of methylparaben, 0.2 to 0.4 part of soybean peptide, 1 to 2 parts of oxido reductase, 1 to 2 parts of hydrolyzed rice bran protein, 0.6 to 0.8 part of polydimethylsiloxane, 0.05 to 0.08 part of propyl hydroxybenzoate, 1 to 2 parts of citric acid, 0.2 to 0.5 part of preservative imidazolidinyl urea, 0.3 to 0.5 part of essence, and 100 parts of deionized water. The eye cream is not oleaginous, easy to apply and comfortable to use, enhances the cell activity performance of eyes, has the advantages of low use level and fastness in becoming effective, can obviously improve the appearance indexes, such as gloss, brightness, viscosity and the like, of the eye cream, does not has side effects, and does not have stimulation and untoward effects on normal human skin.

Description

A kind of moisturizing whitening eye cream
Technical field
The invention belongs to cosmetic technical field, be specifically related to a kind of moisturizing whitening eye cream.
Background technology
Eyelid skin is the skin that Whole Body is the thinnest, and skin is herein the most aging, thus exposes the real age of people.The appearance of usual eye skin old and feeble invariably accompany eye pouch, black eye and crows-feet, the appearance of these outward appearances is normally because physiological change such as the blood circulation of its inherence slows down, supports deficiency and some external factor such as factors such as UV light stimulation to cause.The formation of eye pouch be mostly due to the age increase eye part skin, of flaccid muscles or eye overtired as not having enough sleep, the long-term factor such as to work below computer causes.Black eye are that the eyelid outward appearance at eye socket position presents darker color, relevant to factors such as the vascular flows in the pigment number of eyelid itself, eyelid.
Now eye-care product are commercially more, and effect is single, is some daily moisture retentions mostly, and its composition mostly is the nutritional labeling of artificial chemistry synthesis, and cost is higher.Application in TCM in cosmetics, skin care item and health product historical origin for a long time, and be that main component has at eye black eye of dispelling, the eye cream targetedly of comprehensive effect such as dispel eye pouch, eliminating wrinkle etc. has no report with Chinese medicine.
The appearance of usual eye skin old and feeble invariably accompany eye pouch, black eye and crows-feet, and the appearance of these outward appearances is all because the physiological change of its inherence causes: blood circulation slows down, oxygen supply is not enough and the generation of various stimulation situation, microcirculation slow down, the increase of body internal protein catabolic enzyme burst size/concentration, outside removing human body own physiological reason, some external factor play an important role to skin aging equally as UV light stimulates.Now eye-care product are commercially more, some daily moisturizing and wrinkle removal mostly, in eye eliminating wrinkle, eye pouch of dispelling, black eye of dispelling etc., how to provide to have during a kind of use and strengthen eye cell viability, effectively to suppress and to improve the black-eyed eye cream of eye significant.
Summary of the invention
In order to solve the problems of the technologies described above, the invention provides a kind of moisturizing whitening eye cream, being easy to through mucocutaneous, action effect is remarkable, have and strengthen eye cell viability, effectively suppress and improve the black-eyed function of eye, can greatly improve skin care item sense organ simultaneously.
Technical scheme of the present invention is:
A kind of moisturizing whitening eye cream, it is characterized in that, described eye cream is containing, for example the composition of lower parts by weight: Margarita 3-5 part, Borax 2-4 part, muscone 0.3-0.5 part, oil phase 2-3%, zinc carbonate hydroxide 0.2-0.4 part, alcohol-based mixtures 1-2 part, glycerol monostearate 0.05-0.08 part, nipasol 0.06-0.08 part, glycerol 5-7 part, polyacrylamide 0.8-1 part, EDTA disodium 0.1-0.3 part, methyl hydroxybenzoate 0.2-0.5 part, soybean peptide 0.2-0.4 part, oxidoreductase 1-2 part, hydrolysis rice bran protein 1-2 part, polydimethylsiloxane 0.6-0.8 part, propyl hydroxybenzoate 0.05-0.08 part, citric acid 1-2 part, antiseptic imidazolidinyl urea 0.2-0.5 part, essence 0.3-0.5 part, deionized water 100 parts.
Above-mentioned alcohol-based mixtures be selected from propylene glycol, ethanol, glycerol, sorbitol, octadecanol one or more.
Above-mentioned oil phase is the mixture of olive oil, dimethicone and dimension E oil according to weight ratio 1:2:1 composition.
The beneficial effect of the invention:
Moisturizing whitening eye cream of the present invention, is easy to through mucocutaneous, and without greasy, easy painting exhibition, use comfortable, action effect is remarkable, has and actively promotes ocular circulation, can protect the base support such as collagen protein and elastin laminin tissue; Unnecessary radical ion can be removed; Resist the connective tissue degradation such as free radical, strengthen eye cell viability performance, there is consumption few, the advantage of instant effect, can effectively suppress and improve the black-eyed function of eye, obviously can improve the appearance index such as gloss, brightness, viscosity of eye cream, eye cream be moistened more, is easy to painting exhibition, use rear skinfeel good.Be free from side effects, normal human skin is not stimulated and untoward reaction.
Detailed description of the invention
Embodiment 1
A kind of moisturizing whitening eye cream, it is characterized in that, described eye cream is containing, for example the composition of lower parts by weight:
Margarita 3 parts, Borax 4 parts, muscone 0.3 part, olive oil, the oil phase 3% that dimethicone and dimension E oil form according to weight ratio 1:2:1, zinc carbonate hydroxide 0.2 part, propylene glycol, 2 parts, the mixture that ethanol forms according to 1:2, glycerol monostearate 0.05 part, nipasol 0.08 part, glycerol 5 parts, polyacrylamide 1 part, EDTA disodium 0.1 part, methyl hydroxybenzoate 0.5 part, soybean peptide 0.2 part, oxidoreductase 2 parts, hydrolysis rice bran protein 1 part, polydimethylsiloxane 0.8 part, propyl hydroxybenzoate 0.05 part, citric acid 2 parts, antiseptic imidazolidinyl urea 0.2 part, 0.5 part, essence, deionized water 100 parts.
Embodiment 2
A kind of moisturizing whitening eye cream, it is characterized in that, described eye cream is containing, for example the composition of lower parts by weight:
Margarita 5 parts, Borax 2 parts, muscone 0.5 part, olive oil, the oil phase 2% that dimethicone and dimension E oil form according to weight ratio 1:2:1, zinc carbonate hydroxide 0.4 part, ethanol, 2 parts, the mixture that glycerol forms according to 1:2, glycerol monostearate 0.08 part, nipasol 0.06 part, glycerol 7 parts, polyacrylamide 0.8 part, EDTA disodium 0.3 part, methyl hydroxybenzoate 0.2 part, soybean peptide 0.4 part, oxidoreductase 1 part, hydrolysis rice bran protein 2 parts, polydimethylsiloxane 0.6 part, propyl hydroxybenzoate 0.08 part, citric acid 1 part, antiseptic imidazolidinyl urea 0.5 part, 0.3 part, essence, deionized water 100 parts.
Toxicology test result shows: this product toxicity is extremely low, safe and non-stimulating.Rabbits with Acute eye irritation result of the test shows: test rabbit right eye is after the former cream 0.1ml of instillation the present invention, and test rabbit all shows eye closing, without obvious secretions, without obvious edema, nonirritant of the present invention is described.Repeatedly irritation test result display: continuous use of the present invention 14 days, animal subject shows without systemic toxicity profiles, and skin irritation performance is also without obvious erythema and edema.Human body zest and the display of patch experimental studies results, the present invention is safe and non-stimulating, has no adverse reaction to human body.Irritation test shows, the present invention (90 × 10 -5and 600 × 10 -5interpolation concentration) equal nonirritant under RBC TestSystem test system.Human body patch is tested all experimenters and is all had no adverse reaction, and illustrates that the present invention has no adverse reaction to human body.

Claims (3)

1. a moisturizing whitening eye cream, is characterized in that, described eye cream is containing, for example the composition of lower parts by weight:
Margarita 3-5 part, Borax 2-4 part, muscone 0.3-0.5 part, oil phase 2-3%, zinc carbonate hydroxide 0.2-0.4 part, alcohol-based mixtures 1-2 part, glycerol monostearate 0.05-0.08 part, nipasol 0.06-0.08 part, glycerol 5-7 part, polyacrylamide 0.8-1 part, EDTA disodium 0.1-0.3 part, methyl hydroxybenzoate 0.2-0.5 part, soybean peptide 0.2-0.4 part, oxidoreductase 1-2 part, hydrolysis rice bran protein 1-2 part, polydimethylsiloxane 0.6-0.8 part, propyl hydroxybenzoate 0.05-0.08 part, citric acid 1-2 part, antiseptic imidazolidinyl urea 0.2-0.5 part, essence 0.3-0.5 part, deionized water 100 parts.
2. a kind of moisturizing whitening eye cream according to claim 1, is characterized in that, described alcohol-based mixtures be selected from propylene glycol, ethanol, glycerol, sorbitol, octadecanol one or more.
3. a kind of moisturizing whitening eye cream according to claim 1, is characterized in that, described oil phase is the mixture of olive oil, dimethicone and dimension E oil according to weight ratio 1:2:1 composition.
CN201310497741.0A 2013-10-22 2013-10-22 Hydrating and whitening eye cream Pending CN104546629A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310497741.0A CN104546629A (en) 2013-10-22 2013-10-22 Hydrating and whitening eye cream

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310497741.0A CN104546629A (en) 2013-10-22 2013-10-22 Hydrating and whitening eye cream

Publications (1)

Publication Number Publication Date
CN104546629A true CN104546629A (en) 2015-04-29

Family

ID=53064418

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310497741.0A Pending CN104546629A (en) 2013-10-22 2013-10-22 Hydrating and whitening eye cream

Country Status (1)

Country Link
CN (1) CN104546629A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016199907A1 (en) * 2015-06-12 2016-12-15 Jfeミネラル株式会社 Therapeutic agent for skin wound or rough skin
WO2018105739A1 (en) * 2016-12-09 2018-06-14 Jfeミネラル株式会社 Inorganic composition with excellent property of gradually releasing zinc ion, and production method therefor

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016199907A1 (en) * 2015-06-12 2016-12-15 Jfeミネラル株式会社 Therapeutic agent for skin wound or rough skin
JPWO2016199907A1 (en) * 2015-06-12 2018-03-29 Jfeミネラル株式会社 Skin wound or rough skin treatment
WO2018105739A1 (en) * 2016-12-09 2018-06-14 Jfeミネラル株式会社 Inorganic composition with excellent property of gradually releasing zinc ion, and production method therefor
JPWO2018105739A1 (en) * 2016-12-09 2019-10-24 Jfeミネラル株式会社 INORGANIC COMPOSITION EXCELLENT IN ZINC ION SUSTAINED RELEASE AND METHOD FOR PRODUCING THE SAME
US10987380B2 (en) 2016-12-09 2021-04-27 Jfe Mineral Company, Ltd. Hydrozincite containing zinc carbonate hydroxide hydrate and method of making

Similar Documents

Publication Publication Date Title
CN106236674B (en) A kind of composition with white-skinned face function and its application in cosmetics
CN107875067A (en) Skin care composition and use thereof
CN102973486B (en) Nourishing youth-keeping facial cleanser and preparation method thereof
CN108158931A (en) A kind of moisturizing whitening cream of the extract containing Flos micheliae Albae and preparation method thereof
CN108125892A (en) A kind of marine organism moisture-retention anti-aging cosmetics composition
WO2014191056A1 (en) Combination of active agents for treating skin aging
CN105026358A (en) Novel derivatives of sinapinic acid and the cosmetic or pharmaceutical uses thereof
CN113693955A (en) Essence liquid
CN104490713A (en) Super-soft living spring skin care product with functions of removing foul, tightening, resisting wrinkles and activating skin
CN108309817A (en) A kind of whitening mask Essence and preparation method thereof using resveratrol
CN107898680A (en) A kind of facial mask liquid and preparation method thereof and facial mask
CN104434642A (en) Whitening and moisturizing gel for after-sun repairing and preparation method thereof
CN104546629A (en) Hydrating and whitening eye cream
CN105560090A (en) Skin-activating moisturizing anti-wrinkle face-moisturizing cream
CN111759762A (en) Black eye removing composition, essence and preparation method thereof
CN104224602A (en) Antioxidant facial mask
CN112999124B (en) Eye-protecting spray and preparation method thereof
CN108852938A (en) A kind of compound formulation for the eye pouch that has effects that dispel
CN110151632B (en) Cosmetic composition for nursing eye skin and preparation method thereof
CN112411188A (en) Soybean peptide protein fiber and preparation method and application thereof
CN112402325A (en) Safflower polypeptide reverse-aging cream
CN112370403A (en) Fluorescent and moistening nourishing essence oil containing squalane and preparation method thereof
Dupont et al. From hydration to cell turnover: an integral approach to antiaging
JP2007119433A (en) Useful material such as cosmetic or health food obtained for formulating sake lees extract with rhodiola rosea extract and the like
US20200222296A1 (en) Skin cell energy regeneration by feeding adenosine triphosphate (atp) through topical delivery route

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150429